Cargando…
American Diabetes Association “Standards of Medical Care—2020 for Gestational Diabetes Mellitus”: A Critical Appraisal
INTRODUCTION: Gestational diabetes mellitus (GDM) is a major public health problem, affecting about one in every six pregnancies globally. The guidelines provided by the American Diabetes Association (ADA) on diagnosis and management of hyperglycemia in pregnancy are widely followed. We aim to provi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376815/ https://www.ncbi.nlm.nih.gov/pubmed/32564336 http://dx.doi.org/10.1007/s13300-020-00865-3 |
_version_ | 1783562104323702784 |
---|---|
author | Goyal, Alpesh Gupta, Yashdeep Singla, Rajiv Kalra, Sanjay Tandon, Nikhil |
author_facet | Goyal, Alpesh Gupta, Yashdeep Singla, Rajiv Kalra, Sanjay Tandon, Nikhil |
author_sort | Goyal, Alpesh |
collection | PubMed |
description | INTRODUCTION: Gestational diabetes mellitus (GDM) is a major public health problem, affecting about one in every six pregnancies globally. The guidelines provided by the American Diabetes Association (ADA) on diagnosis and management of hyperglycemia in pregnancy are widely followed. We aim to provide a critical appraisal of the recently published ADA guidance document, highlighting its strength and limitations with regard to the diagnosis of GDM. METHODS AND RESULTS: We reviewed the recent ADA recommendations for the diagnosis and management of hyperglycemia in pregnancy. A periodic update in keeping with the emerging evidence, an inclusive diagnostic approach which increases generalizability, and a clear proposed approach for prenatal testing and postpartum follow-up are strengths of the ADA guidance document. On the other hand, its limitations are a lack of clarity on the applicability of diagnosis of GDM during early pregnancy, use of scientifically inaccurate terms such as “prediabetes” in the context of pregnancy and “overt diabetes prior to gestation” in the definition of GDM, and inconsistent use of terminology between successive publications. Certain issues which merit attention in future publications include a need for uniform global definition of GDM, demarcation of overt diabetes in pregnancy as a distinct entity, clarity on the diagnosis of GDM during early pregnancy, and clear delineation of timelines and appropriate testing strategy for the first prenatal visit. CONCLUSIONS: This article provides a critical appraisal of the recently published ADA guidance document with regard to the diagnosis of GDM. We also share our perspective on issues warranting attention in the future publications. Experts from various professional organizations should aim for a consensus document which can resolve existing controversies in this field, and help clinicians and researchers achieve better health for women in their care. |
format | Online Article Text |
id | pubmed-7376815 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-73768152020-07-27 American Diabetes Association “Standards of Medical Care—2020 for Gestational Diabetes Mellitus”: A Critical Appraisal Goyal, Alpesh Gupta, Yashdeep Singla, Rajiv Kalra, Sanjay Tandon, Nikhil Diabetes Ther Commentary INTRODUCTION: Gestational diabetes mellitus (GDM) is a major public health problem, affecting about one in every six pregnancies globally. The guidelines provided by the American Diabetes Association (ADA) on diagnosis and management of hyperglycemia in pregnancy are widely followed. We aim to provide a critical appraisal of the recently published ADA guidance document, highlighting its strength and limitations with regard to the diagnosis of GDM. METHODS AND RESULTS: We reviewed the recent ADA recommendations for the diagnosis and management of hyperglycemia in pregnancy. A periodic update in keeping with the emerging evidence, an inclusive diagnostic approach which increases generalizability, and a clear proposed approach for prenatal testing and postpartum follow-up are strengths of the ADA guidance document. On the other hand, its limitations are a lack of clarity on the applicability of diagnosis of GDM during early pregnancy, use of scientifically inaccurate terms such as “prediabetes” in the context of pregnancy and “overt diabetes prior to gestation” in the definition of GDM, and inconsistent use of terminology between successive publications. Certain issues which merit attention in future publications include a need for uniform global definition of GDM, demarcation of overt diabetes in pregnancy as a distinct entity, clarity on the diagnosis of GDM during early pregnancy, and clear delineation of timelines and appropriate testing strategy for the first prenatal visit. CONCLUSIONS: This article provides a critical appraisal of the recently published ADA guidance document with regard to the diagnosis of GDM. We also share our perspective on issues warranting attention in the future publications. Experts from various professional organizations should aim for a consensus document which can resolve existing controversies in this field, and help clinicians and researchers achieve better health for women in their care. Springer Healthcare 2020-06-20 2020-08 /pmc/articles/PMC7376815/ /pubmed/32564336 http://dx.doi.org/10.1007/s13300-020-00865-3 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Commentary Goyal, Alpesh Gupta, Yashdeep Singla, Rajiv Kalra, Sanjay Tandon, Nikhil American Diabetes Association “Standards of Medical Care—2020 for Gestational Diabetes Mellitus”: A Critical Appraisal |
title | American Diabetes Association “Standards of Medical Care—2020 for Gestational Diabetes Mellitus”: A Critical Appraisal |
title_full | American Diabetes Association “Standards of Medical Care—2020 for Gestational Diabetes Mellitus”: A Critical Appraisal |
title_fullStr | American Diabetes Association “Standards of Medical Care—2020 for Gestational Diabetes Mellitus”: A Critical Appraisal |
title_full_unstemmed | American Diabetes Association “Standards of Medical Care—2020 for Gestational Diabetes Mellitus”: A Critical Appraisal |
title_short | American Diabetes Association “Standards of Medical Care—2020 for Gestational Diabetes Mellitus”: A Critical Appraisal |
title_sort | american diabetes association “standards of medical care—2020 for gestational diabetes mellitus”: a critical appraisal |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376815/ https://www.ncbi.nlm.nih.gov/pubmed/32564336 http://dx.doi.org/10.1007/s13300-020-00865-3 |
work_keys_str_mv | AT goyalalpesh americandiabetesassociationstandardsofmedicalcare2020forgestationaldiabetesmellitusacriticalappraisal AT guptayashdeep americandiabetesassociationstandardsofmedicalcare2020forgestationaldiabetesmellitusacriticalappraisal AT singlarajiv americandiabetesassociationstandardsofmedicalcare2020forgestationaldiabetesmellitusacriticalappraisal AT kalrasanjay americandiabetesassociationstandardsofmedicalcare2020forgestationaldiabetesmellitusacriticalappraisal AT tandonnikhil americandiabetesassociationstandardsofmedicalcare2020forgestationaldiabetesmellitusacriticalappraisal |